ARTICLE IN ACADEMIC JOURNALS
| NO | DETAILS OF ARTICLE IN ACADEMIC JOURNALS |
|---|---|
| 1. |
THE OUTCOMES OF GLIOBLASTOMA MULTIFORME: THE UNIVERSITY MALAYA MEDICAL CENTRE EXPERIENCE 2008-2018
2024
Author(s) : Marniza Binti Saad, Adlinda Binti Alip Source :
Journal of Health and Translational Medicine
DOI :
10.22452/jummec.vol27no1.7
|
| 2. |
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
2024
Author(s) : Adlinda Binti Alip Source :
Annals of Oncology
DOI :
10.1016/j.annonc.2024.05.541
|
| 3. |
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i>-Mutated Advanced NSCLC
2024
Author(s) : Adlinda Binti Alip Source :
NEW ENGLAND JOURNAL OF MEDICINE
DOI :
10.1056/NEJMoa2403614
|
| 4. |
Amivantamab plus lazertinib vs osimertinib in first-line EGFR<i>-</i>mutant advanced non-small cell lung cancer (NSCLC) with biomarkers of high-risk disease: A secondary analysis from the phase 3 MARIPOSA study
2024
Author(s) : Adlinda Binti Alip Source :
JOURNAL OF CLINICAL ONCOLOGY
|
| 5. |
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
2024
Author(s) : Adlinda Binti Alip Source :
ANNALS OF ONCOLOGY
DOI :
10.1016/j.annonc.2024.05.541
|
| 6. |
Amivantamab plus lazertinib vs osimertinib as first-line treatment in patients with EGFR-mutated, advanced nonsmall cell lung cancer (NSCLC): Primary results from MARIPOSA, a phase III, global, randomized, controlled trial
2023
Author(s) : Adlinda Binti Alip Source :
ANNALS OF ONCOLOGY
DOI :
10.1016/j.annonc.2023.10.062
|
| 7. |
Real-world utilisation of prostate-specific membrane antigen (PSMA) PET-CT in patients with prostate cancer at a tertiary referral centre in Kuala Lumpur
2023
Source :
BJU INTERNATIONAL
|
| 8. |
Evaluation of intrafractional prostate displacement during prostate radiotherapy using real-time ultrasound system
2023
Author(s) : Marniza Binti Saad, Ung Ngie Min, Adlinda Binti Alip, Liew Yih Miin, Zulaikha Binti Jamalludin Source :
PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE
DOI :
10.1007/s13246-023-01230-x
|
| 9. |
The outcomes of glioblastoma multiforme: The University Malaya Medical Centre experience 2008-2018
2023
Author(s) : Adlinda Binti Alip Source :
ANNALS OF ONCOLOGY
DOI :
10.1016/j.annonc.2023.09.213
|
| 10. |
Evaluation of intrafractional prostate displacement during prostate radiotherapy using real-time ultrasound system
2023
Author(s) : Marniza Binti Saad, Ung Ngie Min, Adlinda Binti Alip, Liew Yih Miin, Zulaikha Binti Jamalludin Source :
Physical and Engineering Sciences in Medicine
DOI :
10.1007/s13246-023-01230-x
|
| 11. |
Effectiveness of Decision Aid in Men with Localized Prostate Cancer: a Multicenter Randomized Controlled Trial at Tertiary Referral Hospitals in an Asia Pacific Country
2022
Source :
JOURNAL OF CANCER EDUCATION
DOI :
10.1007/s13187-020-01801-6
|
| 12. |
Barriers of and strategies for shared decision-making implementation in the care of metastatic breast cancer: A qualitative study among patients and healthcare professionals in an Asian country
2022
Author(s) : Nur Aishah Binti Mohd Taib, Adlinda Binti Alip Source :
HEALTH EXPECTATIONS
DOI :
10.1111/hex.13590
|
| 13. |
Effectiveness of Decision Aid in Men with Localized Prostate Cancer: a Multicenter Randomized Controlled Trial at Tertiary Referral Hospitals in an Asia Pacific Country
2022
Source :
Journal of Cancer Education
DOI :
10.1007/s13187-020-01801-6
|
| 14. |
Barriers of and strategies for shared decision-making implementation in the care of metastatic breast cancer: A qualitative study among patients and healthcare professionals in an Asian country
2022
Author(s) : Nur Aishah Binti Mohd Taib, Adlinda Binti Alip Source :
Health Expectations
DOI :
10.1111/hex.13590
|
| 15. |
A phase II, single-arm, open label, Simon two-stage study of pembrolizumab in patients with metastatic HER2-negative breast cancer: Evaluation of impact of germline variants in APOBEC3B (AUROR).
2022
Author(s) : Rozita Binti Abdul Malik, Ho Gwo Fuang, Adlinda Binti Alip, Nur Fadhlina Binti Abdul Satar Source :
JOURNAL OF CLINICAL ONCOLOGY
|
| 16. |
PROSPECTIVE OBSERVATIONAL STUDY OF DEEP INSPIRATION BREATH HOLD (DIBH) IN RADIOTHERAPY FOR LEFT-SIDED BREAST CANCER
2022
Author(s) : Adlinda Binti Alip Source :
Journal of Health and Translational Medicine
DOI :
10.22452/jummec.vol25no2.18
|
| 17. |
Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel
2021
Author(s) : Adlinda Binti Alip Source :
Therapeutic Advances in Medical Oncology
DOI :
10.1177/ 1758835920985464
|
| 18. |
Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel
2021
Author(s) : Shanggar A/l Kuppusamy, Adlinda Binti Alip Source :
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
DOI :
10.1177/1758835920985464
|
| 19. |
Adherence rate and the factors contribute toward the surgical adherence of breast cancer in Malaysia.
2020
Author(s) : Nur Aishah Binti Mohd Taib, Adlinda Binti Alip, Cheng Mao Li, Ng Chong Guan, See Mee Hoong, Tania Islam Source :
Breast Journal
|
| 20. |
Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
2020
Author(s) : Liam Chong Kin, Cheah Phaik Leng, Pang Yong Kek, Ho Gwo Fuang, Adlinda Binti Alip, Poh Mau Ern, Diana Ong Bee Lan Source :
CANCER MANAGEMENT AND RESEARCH
|
| 21. |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of
patients with locally-advanced unresectable non-small-cell lung cancer: a
KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
2020
Author(s) : Adlinda Binti Alip Source :
Annals of Oncology
DOI :
DOI:https://doi.org/10.1016/j.annonc.2019.10.026
|
| 22. |
. 2020 Jun 20. doi: 10.1007/s13187-020-01801-6
2020
Author(s) : Adlinda Binti Alip Source :
J Cancer Education
DOI :
10.1007/s13187-020-01801-6
|
| 23. |
Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort
2020
Source :
CANCER MEDICINE
DOI :
10.1002/cam4.3101
|
| 24. |
Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
2020
Author(s) : Liam Chong Kin, Cheah Phaik Leng, Pang Yong Kek, Ho Gwo Fuang, Adlinda Binti Alip, Poh Mau Ern, Diana Ong Bee Lan Source :
CANCER MANAGEMENT AND RESEARCH
DOI :
10.2147/CMAR.S253760
|
| 25. |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
2020
Author(s) : Adlinda Binti Alip Source :
ANNALS OF ONCOLOGY
|
| 26. |
Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort
2020
Source :
CANCER MEDICINE
DOI :
10.1002/cam4.3101
|
| 27. |
Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study
2019
Source :
BMC CANCER
|
| 28. |
Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017
2019
Source :
BJU INTERNATIONAL
DOI :
10.1111/bju.14807
|
| 29. |
Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference (APCCC) 2017
2019
Source :
BJU INTERNATIONAL
DOI :
10.1111/bju.14807
|
| 30. |
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
2019
Author(s) : Adlinda Binti Alip Source :
ANNALS OF ONCOLOGY
|
| 31. |
Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study
2019
Author(s) : Adlinda Binti Alip Source :
BMC CANCER
|
| 32. |
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
2019
Author(s) : Adlinda Binti Alip Source :
ANNALS OF ONCOLOGY
|
| 33. |
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
2018
Author(s) : Adlinda Binti Alip Source :
Annals of Oncology
DOI :
10.1093/annonc/mdy554
|
| 34. |
The efficacy and tolerability of scalp cooling in preventing chemotherapy induced alopecia in patients with breast cancer receiving anthracycline and taxane based chemotherapy in an Asian setting.
2018
Author(s) : Marniza Binti Saad, Ho Gwo Fuang, Wan Zamaniah Binti Wan Ishak @ Wan Mohammad, Rozita Binti Abdul Malik, Anita Zarina Binti Bustam @ Mainudin, Adlinda Binti Alip Source :
INDIAN JOURNAL OF CANCER
DOI :
10.4103/ijc.IJC_581_17
|
| 35. |
The Efficacy and Tolerability of Scalp Cooling in Prevention of chemotherapy-Induced Alopecia in Patients with Breast cancer Receiving Anthracycline and Taxane-Based Chemotherapy in Asian Setting
2018
Author(s) : Adlinda Binti Alip Source :
Indian Journal of Cancer
|
| 36. |
Single vs multiple fraction palliative radiotherapy for uncomplicated painful bone metastases treated at University of Malaya Medical Centre: A single institutional Malaysian experience.
2018
Author(s) : Marniza Binti Saad, Adlinda Binti Alip Source :
Aging Medicine
DOI :
DOI: 10.1002/agm2.12023
|
| 37. |
Dosage-Dependent Reduction of Macular Pigment Optical Density in Female Breast Cancer Patients Receiving Tamoxifen Adjuvant Therapy
2018
Author(s) : See Mee Hoong, Nur Aishah Binti Mohd Taib, Adlinda Binti Alip, Visvaraja A/l Subrayan, Loo Voon Pei, Khang Tsung Fei Source :
The Breast Journal
DOI :
https://doi.org/10.1016/j.breast.2018.04.003
|
| 38. |
Practical updates in medical therapy for advanced and metastatic renal cell carcinoma
2018
Source :
UROLOGICAL SCIENCE
DOI :
10.4103/UROS.UROS_25_18
|
| 39. |
Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience
2018
Source :
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
|
| 40. |
Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience
2018
Author(s) : Adlinda Binti Alip Source :
Journal of Cancer Research & Therapeutics
DOI :
10.4103/0973-1482.189247
|
| 41. |
Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience
2018
Source :
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
DOI :
10.4103/0973-1482.189247
|
| 42. |
Abiraterone in metastatic castrate resistant prostate cancer: outcome and tolerance in real-world setting
2017
Author(s) : Adlinda Binti Alip Source :
BJUI International Supplement
DOI :
POD17
|
| 43. |
Extended Field Radiotherapy With or Without Chemotherapy in Patients with Cervical Cancer and Positive Para-Aortic Lymph Nodes: a Single Institution Retrospective Review.
2015
Author(s) : Adlinda Binti Alip, Rozita Binti Abdul Malik, Wan Zamaniah Binti Wan Ishak @ Wan Mohammad Source :
Asian Pacific Journal of Cancer Prevention
|
| 44. |
Prospective, non-randomised, open-label study of UDP-gluconoryltransferase (UGT) 2B17 genotype as a predictive marker of exemestane pharmacokinetics (PK) in post-menopausal hormone receptor (HR)-positive Asian metastatic breast cancer (MBC) patients progressing after prior endocrine therapy.
2015
Author(s) : Adlinda Binti Alip, Ho Gwo Fuang Source :
EUROPEAN JOURNAL OF CANCER
|
| 45. |
Treatment Outcome for Head and Neck Squamous Cell Carcinoma in a Developing Country: University Malaya Medical Centre, Malaysia from 2003-2010
2015
Source :
Asian Pacific Journal of Cancer Prevention
|
| 46. |
Capecitabine Pattern of Usage, Rate of Febrile Neutropaenia and Treatment Related Death in Asian Cancer Patients in Clinical Practice
2015
Author(s) : Vincent Phua Chee Ee, Anita Zarina Binti Bustam @ Mainudin, Wan Zamaniah Binti Wan Ishak @ Wan Mohammad, Marniza Binti Saad, Adlinda Binti Alip Source :
Asian Pacific Journal of Cancer Prevention
|
| 47. |
Prognostic Factors in Patients with Non-small Cell Lung Carcinoma and Brain Metastases: a Malaysian Perspective
2015
Source :
Asian Pacific Journal of Cancer Prevention
|
| 48. |
Prostate cancer in multi-ethnic Asian men
2015
Source :
European Journal Of Cancer
DOI :
10.1016/S0959-8049(16)30449-X
|
| 49. |
Chemoradiotherapy in Cervical Cancer - a University of Malaya Medical Centre Experience.
2014
Author(s) : Wan Zamaniah Binti Wan Ishak @ Wan Mohammad, Mastura Binti Md Yusof, Vincent Phua Chee Ee, Rozita Binti Abdul Malik, Marniza Binti Saad, Adlinda Binti Alip Source :
Asia Pacific Journal of Cancer Prevention
|
| 50. |
Risk of Treatment Related Death and Febrile Neutropaenia with First Line Palliative Chemotherapy for De Novo Metastatic Breast Cancer in Clinical Practice in a Middle Resource Country
2014
Author(s) : Vincent Phua Chee Ee, Marniza Binti Saad, Mastura Binti Md Yusof, See Mee Hoong, Nur Aishah Binti Mohd Taib, Adlinda Binti Alip Source :
Asian Pacific Journal of Cancer Prevention
|
PROCEEDING
| NO | DETAILS OF PROCEEDING |
|---|---|
| 1. |
OA02.05 Lazertinib vs Osimertinib in 1L EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis from MARIPOSA
2024
Author(s) : Adlinda Binti Alip |
| 2. |
TP53 Co-mutations, Sites of Insertion, and ctDNA Clearance Among Patients with EGFR Ex20ins-Mutated Advanced NSCLC
2024
Author(s) : Adlinda Binti Alip |
| 3. |
Amivantamab Plus Lazertinib vs Osimertinib as First-line Treatment in Patients With EGFR-mutated, Advanced Non-small Cell Lung Cancer (NSCLC): Primary Results From MARIPOSA, a Phase 3, Global, Randomized, Controlled Trial
2023
Author(s) : Adlinda Binti Alip |
| 4. |
Amivantamab Plus Lazertinib vs Osimertinib as First-line Treatment Among Asian Patients With EGFR-mutated, Advanced Non-small Cell Lung Cancer (NSCLC): MARIPOSA Subgroup Analysis
2023
Author(s) : Adlinda Binti Alip |
| 5. |
Abiraterone in metastatic castrate resistant prostate cancer: outcome and tolerance in real-world setting.
2017
|
| 6. |
Treatment outcomes of patients with Metastatic Castrate Resistant Prostate Cancer (MCRPC) on first line docetaxel chemotherapy at University Malaya Medical Centre.
2016
Author(s) : Marniza Binti Saad, Adlinda Binti Alip |
| 7. |
Diagnostic Dilemma: A case of Metastatic Tubulocystic Carcinoma of the Kidney.
2016
Author(s) : Adlinda Binti Alip |
| 8. |
Real-World experience with abiraterone in metastatic castrate resistant prostate carcinoma in University Malaya Medical Centre.
2016
Author(s) : Marniza Binti Saad, Adlinda Binti Alip |
| 9. |
The unusual kid on the block:Primary Renal Ewing Sarcoma
2016
Author(s) : Marniza Binti Saad, Adlinda Binti Alip |
| 10. |
The Treatment Outcome of Metastatic Prostate Cancer Patients Treated with Androgen Deprivation Therapy in UMMC.
2016
Author(s) : Adlinda Binti Alip |
| 11. |
Efficacy and safety of first line sunitinib in patients with metastatic renal cell cancer: a Malaysian experience from a single tertiary centre.
2015
Author(s) : Adlinda Binti Alip |
| 12. |
Postmastectomy radiotherapy is not associated with a survival advantage in breast cancer patients with low axillary nodal burden
2014
Author(s) : Adlinda Binti Alip |
| 13. |
Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for NSCLC: experience from nine UK centres.
2014
Author(s) : Adlinda Binti Alip |
| 14. |
Treatment Outcome of Preoperative Pelvic Chemoradiation for Rectal Carcinoma in a Middle Income Country
2013
Author(s) : Adlinda Binti Alip, Marniza Binti Saad |
| 15. |
Outcome of Routine Radioiodine Ablation for Differentiated Thyroid Cancer in an Academic Institution in Kuala Lumpur, Malaysia
2013
Author(s) : Adlinda Binti Alip, Mastura Binti Md Yusof, Rozita Binti Abdul Malik, Vincent Phua Chee Ee |
| 16. |
Treatment with continuous, hyperfractionated, accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC): experience from five UK centres between 2005-2010.
2011
Author(s) : Adlinda Binti Alip |
| 17. |
Continuous hyperfractionated accelerated radiotherapy (CHART) for patients with inoperable non-small cell lung Cancer( NSCLC): 10 year experience of the Exeter Oncology Centre
2011
Author(s) : Adlinda Binti Alip |
| 18. |
Rate of febrile neutropenia in breast cancer patients receiving adjuvant chemotherapy with FEC and Taxotere.
2010
Author(s) : Adlinda Binti Alip |
| 19. |
Audit of Chemotherapy for Metastatic Colorectal Carcinoma between 1st April 2006 and 31st March 2007 according to NICE Guidelines.
2007
Author(s) : Adlinda Binti Alip |
RESEARCH COLLABORATOR
| GRANT | PROGRESS | STATUS |
|---|---|---|
|
Dosimetric And Treatment Plan Assessment Of Stereotactic Radiosurgery And Stereotactic Body Radiotherapy In Malaysia
|
|
on going |
|
Understanding Pattern Of Prostate Motion Through Real-time Tracking For Optimizing Duration-dependent Radiotherapy Treatment Margins
|
|
end |
|
Clinical And Molecular Investigation On The Role Of Cholesterol In Improving Drug Response In Bladder Cancer
|
|
end |
|
Multidisciplinary Point of Care Data Capture for Innovative Healthcare: The I-pesakit Breast Cancer Module Prototype, enhancement of the University Malaya Medical Centre I-pesakit Electronic Medical Records
Researcher(s) : Prof. Dr. Nur Aishah Binti Mohd Taib, Associate Prof. Dr. Adlinda Binti Alip, Associate Prof. Dr. Teoh Kean Hooi, Prof. Dr. Kartini Binti Rahmat, Dr. Tania Islam, Dr. Kiran Kaur A/p Amer Singh, Associate Prof. Dr. Suniza Binti Jamaris, Hana Salwani Mohd Zaini, Izam Ezri Bin Mohd Zakaria |
|
end |
|
Differentiation between recurrence and radiation necrosis post treatment of glioma.
|
|
end |